Therefore, the opioid system plays a critical role in maintaining gastrointestinal homeostasis, and targeting the endogenous opioid system with peptidase inhibitors intervention may be a promising therapeutic strategy for the prevention or treatment of IBD. Here, LAP3 is linked to inflammatory bowel disease.